Cargando…
Prediction of QcrB Inhibition as a Measure of Antitubercular Activity with Machine Learning Protocols
[Image: see text] It has always been a challenge to develop interventional therapies for Mycobacterium tuberculosis. Over the years, several attempts at developing such therapies have hit a dead-end owing to rapid mutation rates of the tubercular bacilli and their ability to lay dormant for years. R...
Autores principales: | Khan, Afreen A., Poojary, Sannidhi S., Bhave, Ketki K., Nandan, Santosh R., Iyer, Krishna R., Coutinho, Evans C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161412/ https://www.ncbi.nlm.nih.gov/pubmed/35664614 http://dx.doi.org/10.1021/acsomega.2c01613 |
Ejemplares similares
-
Improved Phenoxyalkylbenzimidazoles with Activity
against Mycobacterium tuberculosis Appear to Target
QcrB
por: Chandrasekera, N. Susantha, et al.
Publicado: (2017) -
Identification
of Morpholino Thiophenes as
Novel Mycobacterium tuberculosis Inhibitors, Targeting
QcrB
por: Cleghorn, Laura A. T., et al.
Publicado: (2018) -
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
por: Foo, Caroline S., et al.
Publicado: (2018) -
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
por: Abrahams, Katherine A., et al.
Publicado: (2012) -
Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis
por: Harrison, Gregory A., et al.
Publicado: (2019)